TP53 and neoplasm: The p53-independent potentiation effect was also observed with the combination of GSK2830371 and doxorubicin, although doxorubicin exerts its anti-tumor activity through a number of proposed mechanisms of action, and thus, the mechanism relevant to this study could not be elucidated.